China Animal Vaccine Industry Report, 2010-2011
  • Aug/2011
  • Hard Copy
  • USD $2,100
  • Pages:86
  • Single User License
    (PDF Unprintable)       
  • USD $2,000
  • Code: HM004
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,100
  • Hard Copy + Single User License
  • USD $2,300
China animal vaccine industry has been fast-growing. The market maintained an average annual growth rate up to 13.6% in 2006-2010, and reached around RMB 7.5 billion in 2010, up 21.0% YoY. With the increase of the state investment in animal epidemic funds, the expansion of compulsory immunization against animal epidemics and immunization scope as well as the strengthening of China livestock breeding industry standardization, China animal vaccine industry is expected to continue to maintain a relatively high growth momentum in future.

Market Scale and YoY Growth Rate of China Animal Vaccine Industry, 2006-2010 (Unit: RMB bn)
Source: ResearchInChina

Although there are nearly 60 animal vaccine manufacturers in China, the market share is concentrated in the hands of a few enterprises. CAHIC, Yebio QD, Guangdong Dahuanong Animal Health Products, Tecon and Chengdu Tech-Bank are representatives of China animal vaccine industry, accounting for a market share of 37.4%. Sales of these companies mainly come from the government procurement of compulsory vaccines, wherein, the revenue from government compulsory vaccines accounted for 88% of the total animal vaccine revenue of CAHIC in 2010.

According to China’s compulsory immunization plan against animal epidemics in recent three years, China not only expands the application scope of the existing animal immunization products, but also attaches great importance to the upgrading of animal vaccine products at the same time. The applications of high-performance passage cell-derived vaccine, synthesis peptide vaccine, etc. are gradually being expanded, e.g., Classical Swine Fever Vaccine, Live (Cell Line Origin) expanded its application coverage from eight provinces in 2010 to sixteen provinces in 2011.

However, due to the high requirements on technology and equipment from passage cell-derived vaccine, synthesis peptide vaccine, etc., there are limited manufacturers available right now. Although CAHIC, Tecon, etc all start their layout in the field of Classical Swine Fever Vaccine, Live (Cell Line Origin), Guangdong Winsun Bio-pharmaceutical is still the major supplier in present market. Tecon, Shanghai Shenlian, CAHIC, etc involve in production and sales of synthesis peptide vaccine, but CAHIC produces synthesis peptide vaccine by purchasing antigen from Shanghai Shenlian.

In recent year, the scope of China animal compulsory vaccination is being gradually expanded. Constrained by economic conditions, the compulsory immunization against animal epidemics currently only contains five kinds of Epidemics of Class I, while there are about 17 kinds of Epidemic of Class I in China and other epidemics lead to greater risk as well. With the increasing recognition of animal epidemic prevention and control from breeding enterprises and individuals, the future demand for conventional self-pay vaccine will be further enhanced. As China livestock breeding relies mainly on raising pig and poultry, Newcastle disease vaccine and porcine circovirus vaccine will be two conventional vaccines with pretty good market prospects.
1. Overview of Animal Vaccine
1.1 Definition & Classification of Animal Vaccines
1.2 Definition & Classification of Animal Biological Products
1.3 Industry Chain

2. Operating Environment for Animal Vaccine Industry 
2.1 Macro Environment
2.2 Policy Environment
2.3 Social Environment
2.4 International Environment
2.4.1 Market Scale
2.5 Overview of Vaccine Market

3. Development of Animal Vaccine Industry in China
3.1 Overview
3.2 Market Scale
3.3 Supply & Demand
3.4 Market Competition
3.5 Import and Export
3.5.1 Export
3.5.2 Import
3.6 Development Prospect

4. Animal Vaccine Market Segments in China
4.1 Swine Vaccines
4.1.1 Classical Swine Fever Vaccine
4.1.2 Pig Foot and Mouth Disease Vaccine
4.1.3 PRRS Vaccine
4.1.4 Porcine Circovirus Vaccine
4.2 Poultry Vaccines
4.2.1 Newcastle Disease Vaccine
4.3 Cattle & Sheep Vaccines
4.4 Pet Vaccines

5. Key Enterprises
5.1.1 Profile
5.1.2 Operation
5.1.3 Animal Vaccine Business
5.1.4 Development Prospect & Advantages of Animal Vaccine Business 
5.2 Jinyu Group
5.2.1 Profile
5.2.2 Operation
5.2.3 Animal Vaccine Business
5.2.4 Development Prospect & Advantages of Animal Vaccine Business
5.3 Tecon
5.3.1 Profile
5.3.2 Operation
5.3.3 Animal Vaccine Business
5.3.4 Development Prospect of Animal Vaccine Business
5.4 Ningbo Tech-Bank
5.4.1 Profile
5.4.2 Operation
5.4.3 Chengdu Tech-Bank (formerly Chengdu Jinghua)
5.5 Shenghua Biok
5.5.1 Profile
5.5.2 Operation
5.5.3 Yebio QD
5.6 Huasun Group
5.6.1 Profile
5.6.2 Operation
5.6.3 Sichuan Huasun
5.7 Harbin Pharmaceutical Group
5.7.1 Profile
5.7.2 Status Quo & Prospect of Animal Vaccine Business 
5.8 Tianjin Ringpu Bio-technology 
5.8.1 Profile
5.8.2 Operation
5.8.3 Status Quo & Prospect of Animal Vaccine Business 
5.9 Guangdong Dahuanong Animal Health Products
5.9.1 Profile
5.9.2 Operation
5.9.3 Status Quo & Prospect of Animal Vaccine Business
5.10 Foreign Enterprises in China
5.10.1 Merial
5.10.2 Boehringer-Ingelheim
5.10.3 Bayer
5.10.4 Novartis
5.10.5 Pfizer
Animal Vaccine Types and Characteristics
Animal Vaccine Industry Chain
Amount of Livestock on Hand in China, 2005-2010
Classification of Animal Disease 
China’s GDP Growth Rate, 2007-2011Q2
Major Policies Related to Animal Vaccine Industry, As of 2010 
China’s Meat, Poultry & Egg and Milk Output, 2007-2010 
Global Animal Vaccine Market Scale, 2004 & 2008-2010
Vaccine Sales of Global Top 5 Vaccine Manufacturers, 2007-2010 
Main Mergers & Acquisitions in the Vaccine Industry Worldwide, 2005-Apr.2011
Market Size of Human Vaccine and Animal Vaccine in China, 2007-2010
EPI Vaccine Varieties in China, 2010
Gross Margin of Major Vaccine Manufacturers in China, 2007-2010
Mandatory Animal Disease Immunization Programs of China, 2009-2011 
China’s Animal Vaccine Market Share by Category, 2009-2010
China’s Animal Vaccine Industry Market Scale & Growth, 2006-2010 
Major Manufacturers of Animal Vaccines in China
Production of China’s Key Animal Vaccine Manufacturers
China’s Animal Vaccine Consumption Structure by Animal Species, 2009-2010
China’s Animal Vaccination Program, 2011
Market Shares of China’s Main Animal Vaccine Manufacturers by Sales, 2010
Manufacturers of Government Procurement Vaccines, 2008-2010
Compulsory Vaccination Products of Listed Animal Vaccine Companies, 2010 
China’s Animal Vaccine Export Volume, Value and Average Unit Price, 2007-2010
China’s Animal Vaccine Oversea Market Distribution, 2010
China’s Animal Vaccine Import Volume, Value and Average Unit Price, 2007-2010
Origins of China’s Imported Animal Vaccines, 2010
China’s Animal Vaccine Industry Development Driving Forces
M & A of Animal Vaccine Enterprises in China, by Aug 2011 
China’s Pig Inventory and Slaughter Quantity, 2000-2010
China’s Pig Vaccine Market Scale, 2008-2010
China’s Pet Vaccine Suppliers
Performance Comparison of China’s Various Hog Cholera Vaccines
Designated FMD Vaccine Manufacturers and Their Market Shares, 2010
PRRS Vaccine Prices 
China’s Poultry Vaccine Market Scale, 2008-2010
Major Poultry Vaccine Varieties and Manufacturers in China
Market Capacity of Newcastle Disease Vaccine and Market Share of Tianjin Ringpu Bio-technology
Cattle & Sheep Vaccine Market Scale, 2008-2010 
China’s Pet Vaccine Market Scale, 2008-2010 
Operating Revenue and Net Income of CAHIC, 2007-2011Q1 
Operating Revenue & Structure by Business of CAHIC, 2007-2010
Operating Revenue of CAHIC by Region, 2008-2010
Animal Vaccine Capacity Distribution of CAHIC
Animal Vaccine Sales Volume by Category of CAHIC, 2007-2010 
Animal Vaccine Operating Income and Gross Margin of CAHIC, 2007-2010 
Operating Revenue and Net Income of Jinyu Group, 2007-2011Q1 
Operating Revenue & Structure by Business of Jinyu Group, 2007-2010 
Operating Income and Operating Margin of Jinyu Group, 2008-2010
Operating Revenue by Region of Jinyu Group, 2008-2010
Animal Vaccine Capacity Distribution of Jinyu Group
Animal Vaccine Revenue and Gross Margin of Jinyu Group, 2007-2010
R&D Advantages of Jinyu Group
Operating Revenue and Net Income of Tecon, 2007-2011Q1 
Operating Revenue and Structure by Business of Tecon, 2007-2010 
Operating Income and Operating Margin of Tecon, 2008-2010
Ratio of R&D Input to Operating Revenue of Tecon, 2007-2010
Operating Revenue by Region of Tecon, 2008-2010
Animal Vaccine Revenue and Gross Margin of Tecon, 2007-2010
Progress of Animal Vaccine R&D of Tecon, As of 2010
Operating Revenue and Net Income of Ningbo Tech-Bank, 2008-2011Q1 
Operating Revenue and Structure by Business of Ningbo Tech-Bank, 2008-2010 
Gross Margin by Product of Ningbo Tech-Bank, 2008-2010
Operating Revenue and Operating Income of Chengdu Tech-Bank, 2008-2010
Operating Revenue and Net Income of Shenghua Biok, 2007-2011Q1
Operating Revenue and Structure by Business of Shenghua Biok, 2007-2010 
Operating Margin of Shenghua Biok, 2007-2010
Operating Revenue Structure of Shenghua Biok by Region, 2008-2010
Operating Revenue and Net Income of Yebio QD, 2008-2010 
Operating Revenue and Net Income of Huasun Group, 2007-2011Q1 
Operating Revenue and Structure by Business of Huasun Group, 2008-2010 
Gross Margin by Business of Huasun Group, 2007-2010
Operating Revenue and Net Income of Sichuan Huasun, 2008-2010
Operation of Harbin Pharmaceutical Group, 2008-2009
Operating Revenue and Net Income of Tianjin Ringpu Bio-technology, 2008-2011H1
Sales of Tianjin Ringpu Bio-technology by Product, 2008-2010
Gross Margin of Tianjin Ringpu Bio-technology by Product, 2007-2010
Sales Revenue from Governmental Tendering and Its ratio of Tianjin Ringpu Bio-technology, 2008-2010
R & D Input and Its Ratio to Operating Revenue of Tianjin Ringpu Bio-technology, 2008-2010
Animal Vaccine Revenue of Tianjin Ringpu Bio-technology by Product, 2007-2010H1
Operating Revenue and Net Income of Guangdong Dahuanong Animal Health Products, 2008-2011Q1
Sales of Guangdong Dahuanong Animal Health Products by Product, 2008-2010
Gross Margin of Guangdong Dahuanong Animal Health Products by Product, 2007-2010
R & D Input and Its Ratio to Operating Revenue of Guangdong Dahuanong Animal Health Products, 2008-2010
Main Animal Vaccine Products of Guangdong Dahuanong Animal Health Products
Vaccine Projects under R&D and Their Progress of Dahuanong Animal Health Products, As of 2010
Animal Vaccine Products of Boehringer-Ingelheim in China Market, As of 2010

China Contract Research Organization (CRO) Industry Report, 2020-2026

The contract research organization (CRO) industry has been galloping amid the global pharmaceutical market steadily in head way, the vibrant financing in the medical and health sector, and the prolife...

China Human Vaccine Industry Report, 2020-2026

In China, the lot release for human vaccines plunged by 17.7% in 2018 when the production record fraud of rabies vaccines for human use, freeze-dried by Changsheng Bio-Technology was exposed. The impa...

China Pharmaceutical Distribution Industry Report, 2019-2026

The Chinese pharmaceutical distribution market has been expanding steadily over the recent years, being valued at RMB2,330.3 billion in 2019 with a year-on-year increase of 8.9%, of which the pharmace...

China Pharmaceutical Distribution Industry Report, 2019-2025

China’s pharmaceutical distribution industry has sustained steady growth over the years. In 2018, the market was worth RMB2,194.5 billion, a 9.6% rise from RMB2,001.6 billion (up by 8.4% YoY) in 2017,...

China Pharmaceutical Packaging Industry Report, 2019-2025

Being incentivized by the burgeoning pharmaceuticals industry, Chinese pharmaceutical packaging market size sustained growth rates of around 10% in recent years, and outstripped RMB100 billion in 2018...

China Blood Product Industry Report, 2018-2022

The blood product industry in China develops under stimulation of industry policies and downstream demand. The country recorded total lot release volume of 64.11 million bottles of blood products in 2...

China Pharmaceutical Distribution Industry Report, 2017-2021

The Chinese pharmaceutical distribution market has developed steadily but at a slower rate in recent years. The industry rose by 10.4% year on year to RMB1.8393 trillion in 2016 and is expected to hit...

China Blood Product Industry Report, 2017-2021

China’s blood product market size mushroomed in 2016 under the impetus of liberalization of limited-price policy, price rises in varying degrees and lot release volume growth for blood products in 201...

China Pharmaceutical Packaging Industry Report, 2016-2021

Under the impetus of the fast-growing downstream pharmaceutical industry, Chinese pharmaceutical packaging market size increased year by year at the CAGR of 11.2% during 2010-2016. From 2017 to 2021, ...

China Pharmaceutical Glass Packaging Industry Report, 2014-2017

In recent years, advances in new healthcare reform have boosted market demand from China pharmaceuticals industryand driven growth in the demand from pharmaceutical packaging industry. In 2014, the Ch...

China Vitamin Industry Report,2014-2017

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...

China Pharmaceutical Distribution Industry Report, 2013

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...

China Pharmaceutical Glass Packaging Industry Report, 2013-2016

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...

China Chinese Patent Medicine Industry Report, 2013-2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...

Global and China Insulin Industry Report, 2013-2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...

China Vitamin Industry Report, 2012-2015

As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...

2005- All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号